Arkolith/Insider Trading/SKYE/Form 4

Schwab Andrew J.

Director, 10% OwnerSkye Bioscience, Inc. (SKYE) · full profile →Form 4 · filed Aug 22, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2023Grant(A)10.6M——10.6M
Aug 18, 2023Grant(A)684.4M$0.01$6.8M684.4M
Aug 18, 2023Grant(A)161.9M$0.01$1.6M429.5M
Aug 18, 2023Grant(A)6.4M$0.01$64K16.9M
Aug 18, 2023Grant(A)267.6M——267.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 18, 2023Grant(A)426.3M—$0426.3M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001516551-23-000052) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML